Ferriss JS - Search Results

1

Current Treatment Options: Uterine Sarcoma.

Lewis D, Liang A, Mason T, Ferriss JS. Lewis D, et al. Among authors: ferriss js. Curr Treat Options Oncol. 2024 Jul;25(7):829-853. doi: 10.1007/s11864-024-01214-3. Epub 2024 May 31. Curr Treat Options Oncol. 2024. PMID: 38819624 Review.

2

Immunotherapy: Checkpoint Inhibitors in Lynch-Associated Gynecologic Cancers.

Ferriss JS, Williams-Brown MY. Ferriss JS, et al. Curr Treat Options Oncol. 2019 Aug 23;20(10):75. doi: 10.1007/s11864-019-0676-8. Curr Treat Options Oncol. 2019. PMID: 31444655 Review.

3

Uterine serous carcinoma: key advances and novel treatment approaches.

Ferriss JS, Erickson BK, Shih IM, Fader AN. Ferriss JS, et al. Int J Gynecol Cancer. 2021 Aug;31(8):1165-1174. doi: 10.1136/ijgc-2021-002753. Epub 2021 Jul 1. Int J Gynecol Cancer. 2021. PMID: 34210768 Review.

4

Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study.

Erickson BK, Najjar O, Damast S, Blakaj A, Tymon-Rosario J, Shahi M, Santin A, Klein M, Dolan M, Cimino-Mathews A, Buza N, Ferriss JS, Stone RL, Khalifa M, Fader AN. Erickson BK, et al. Among authors: ferriss js. Gynecol Oncol. 2020 Oct;159(1):17-22. doi: 10.1016/j.ygyno.2020.07.016. Epub 2020 Jul 21. Gynecol Oncol. 2020. PMID: 32709539 Free PMC article.

5

Incorporation of immunotherapy into the treatment of metastatic neuroendocrine carcinoma of the cervix: A case report.

Suresh A, Ferriss JS. Suresh A, et al. Among authors: ferriss js. Gynecol Oncol Rep. 2023 Aug 22;49:101263. doi: 10.1016/j.gore.2023.101263. eCollection 2023 Oct. Gynecol Oncol Rep. 2023. PMID: 37663173 Free PMC article.

6

The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates.

Acosta-Torres S, Murdock T, Matsuno R, Beavis AL, Stone RL, Wethington SL, Levinson K, Grumbine F, Ferriss JS, Tanner EJ, Fader AN. Acosta-Torres S, et al. Among authors: ferriss js. Gynecol Oncol. 2020 May;157(2):348-356. doi: 10.1016/j.ygyno.2020.02.008. Epub 2020 Feb 19. Gynecol Oncol. 2020. PMID: 32085863

7

Enough already: Is this the end of comprehensive lymphadenectomy in endometrial cancer or are further trials needed?

Ferriss JS, Fader AN. Ferriss JS, et al. Gynecol Oncol. 2019 Nov;155(2):175-176. doi: 10.1016/j.ygyno.2019.10.016. Gynecol Oncol. 2019. PMID: 31677650 No abstract available.

8

Are ethnic and racial minority women less likely to participate in clinical trials?

Patel SN, Staples JN, Garcia C, Chatfield L, Ferriss JS, Duska L. Patel SN, et al. Among authors: ferriss js. Gynecol Oncol. 2020 May;157(2):323-328. doi: 10.1016/j.ygyno.2020.01.040. Epub 2020 Apr 3. Gynecol Oncol. 2020. PMID: 32253046

9

Society of Gynecologic Oncology recommendations for fellowship education during the COVID-19 pandemic and beyond: Innovating programs to optimize trainee success.

Ferriss JS, Rose S, Rungruang B, Urban R, Spencer R, Uppal S, Sinno AK, Duska L, Walsh C. Ferriss JS, et al. Gynecol Oncol. 2021 Jan;160(1):271-278. doi: 10.1016/j.ygyno.2020.10.009. Epub 2020 Oct 17. Gynecol Oncol. 2021. PMID: 33077260 Free PMC article. Review.

10

Integrating Social Needs Screening and Resource Referral Into Standard Ambulatory Oncology Care: A Quality Improvement Project.

Wethington SL, Rositch AF, Yu R, Bielman M, Topel K, Stone RL, Ferriss JS, Fader AN, Beavis AL. Wethington SL, et al. Among authors: ferriss js. JCO Oncol Pract. 2024 Apr;20(4):566-571. doi: 10.1200/OP.23.00485. Epub 2024 Jan 26. JCO Oncol Pract. 2024. PMID: 38277618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters